Biotechnology Value Trading Fund OS LP: insider trades.
Biotechnology Value Trading Fund OS LP reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Biotechnology Value Trading Fund OS LP
Companies
| Company | Relationship | Transactions |
|---|---|---|
| XOMA Royalty Corp (XOMA) | TenPercentOwner, Other | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-14 | XOMA Royalty Corp | U | 412,000 | — | 0 | Form 4 |
| 2026-07-14 | XOMA Royalty Corp | U | 2,773,545 | — | 0 | Form 4 |
| 2026-07-14 | XOMA Royalty Corp | U | 3,635,758 | — | 0 | Form 4 |
| 2026-07-14 | XOMA Royalty Corp | U | 772,000 | — | 0 | Form 4 |
Questions
What stock did Biotechnology Value Trading Fund OS LP buy or sell?
Biotechnology Value Trading Fund OS LP reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.
Is Biotechnology Value Trading Fund OS LP the same person as other filers with this name?
This page covers SEC CIK 1660683 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Plain-text version for agents and LLMs: /insiders/biotechnology-value-trading-fund-os-lp-1660683.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.